Last reviewed · How we verify
NCT03491514
Glycemic and Insulinemic Impact of a Test Granola 3 Versus a Control Granola
NA trial testing Test Granola in Glycemic Response in 40 participants. Completed in 1 June 2018.
31 May 2018
Quick facts
| Lead sponsor | PepsiCo Global R&D |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | double |
| Primary purpose | basic science |
| Enrollment | 40 |
| Start date | 17 January 2018 |
| Primary completion | 31 May 2018 |
| Estimated completion | 1 June 2018 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Test Granola
- Control Granola
Conditions studied
- Glycemic Response — all drugs for Glycemic Response →
- Insulinemic Response — all drugs for Insulinemic Response →
- Subjectvie Hunger — all drugs for Subjectvie Hunger →
Sponsor
PepsiCo Global R&D — full company profile →
Who can join
Adults 18 to 65, any sex, with Glycemic Response or Insulinemic Response. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objectives of this study are to examine the blood glucose and serum insulin response elicited by servings of Test Granola and Control Granola containing equal amounts of available carbohydrate over a 3 h time period. In addition, the subjective hunger response to these foods will be measured over 3 h.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Decreasing the RAG:SAG ratio of granola cereal predictably reduces postprandial glucose and insulin responses: a report of four randomised trials in healthy adults.
Wolever TMS, Jenkins AL, Campbell JE, Ezatagha A, et al · · 2022 · PMID 35399553 · DOI 10.1017/jns.2022.22
Verify or expand the search:
- PubMed search for NCT03491514
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Test Granola
Trials testing the same drug.
- NCT03493022 — Glycemic and Insulinemic Impact of a Test Granola 2 Versus a Control Granola · NA · completed
- NCT03495778 — Glycemic and Insulinemic Impact of a Test Granola Versus a Control Granola · NA · completed
Other recruiting trials for Glycemic Response
Currently open trials in the same condition.
- NCT04881019 — PRediction Of Glycemic RESponse Study · active not recruiting
Other PepsiCo Global R&D trials
Trials by the same sponsor.
- NCT07429201 — Comparing an Electrolyte-Carbohydrate Beverage to Water During Ramadan · NA · completed
- NCT07400614 — Evaluating the Impact of Energy Drink Formulas on Alertness for an Extended Period · NA · recruiting
- NCT07427654 — Determination of the Glycemic Index of Products Varying in Levels of Refined and Whole Grain Corn · NA · completed
- NCT07298863 — The Effect of Hydration Status on Substrate Oxidation at Rest and During Light and Moderate Exercise · NA · recruiting
- NCT07217834 — Effects of a Glycerol-Electrolyte Beverage on Fluid Balance in Healthy Euhydrated Men and Women · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03491514 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by PepsiCo Global R&D
- Last refreshed: 14 September 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03491514.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing